甲托雷克萨特相关的系统性淋巴腺病变显示出血清IgG4度明显升高
Yasuhiro Masuta1, Naoya Omaru1, Yasuo Otsuka1
1Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Japan.
甲托雷克萨特 (MTX) 可以导致淋巴增殖性疾病 (MTX-LPDs). 血清IgG4升高可能作为MTX-LPD的生物标志物,当活检是不可行的时,有助于治疗决策.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 甲托雷克萨特 (MTX) 是类风湿性关节炎的主要治疗方法.
- 接受MTX治疗的患者面临MTX相关淋巴增殖性疾病 (MTX-LPDs) 的风险增加.
- 诊断MTX-LPD通常需要病理评估,但由于病变位置或MTX停用后的快速回归,活检通常是不切实际的.
研究的目的:
- 在活检不可行时,调查MTX-LPD的潜在生物标志物.
- 探索血清IgG4在预测MTX-LPD对MTX停止反应中的作用.
主要方法:
- 关于MTX相关的全身淋巴腺病变的病例报告.
- 对受影响患者血清IgG4度的分析.
主要成果:
- 这位患者出现了全身性淋巴腺病.
- 观察到血清IgG4度明显升高.
- 这些发现表明高血清IgG4和MTX-LPD之间的相关性.
结论:
- 血清IgG4升高可能表明MTX-LPD.
- 血清IgG4显示出作为MTX-LPD的非侵入性生物标志物的潜力.
- 这种生物标志物可能有助于在活检不是一种选择时管理患者.
更多相关视频
06:35An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
